ADIA (Adia Med) Accounts Receivable: $0.04 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADIA Adia Med Inc ADIA
20 GF Score
Price $0.12
! 5 Warning Signs
View Full Analysis

What is Adia Med Accounts Receivable?

Adia Med ADIA 20 Accounts Receivable is $0.04 Mil as of Jun. 2026. GuruFocus rates ADIA with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Adia Med's accounts receivables for the quarter that ended in Jun. 2026 was $0.04 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Adia Med's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 8.28.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Adia Med's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was $-0.01.


Adia Med Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Adia Med's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.044/0.485*91
=8.28

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Adia Med's accounts receivable are only considered to be worth 75% of book value:

Adia Med's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.128+0.75 * 0.044+0.5 * 0.141-1.124
-0.002-0)/94.405
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Adia Med Accounts Receivable Related Terms


Adia Med Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Adia Med's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adia Med Accounts Receivable Chart

Adia Med Annual Data
Trend Dec24 Dec25
Accounts Receivable
0.00 0.03

Adia Med Quarterly Data
Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.11 0.03 0.08 0.04
ADIA
20GF Score
Adia Med Inc ADIA
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adia Med Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of $0.04 Mil mean?
Adia Med (ADIA) has a Accounts Receivable of $0.04 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Adia Med and its competitors.
Is Adia Med's Accounts Receivable too high?
Adia Med's current Accounts Receivable is $0.04 Mil. Overall, Adia Med has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's Accounts Receivable compare to SYRA and GBCS?
Adia Med's Accounts Receivable of $0.04 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Adia Med and its competitors. Adia Med's current Accounts Receivable is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current Accounts Receivable of $0.04 Mil. The current Accounts Receivable is $0.04 Mil. Adia Med's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Adia Med (ADIA), the current Accounts Receivable is $0.04 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adia Med Business Description

Address 1561 West Fairbanks Avenue, Suite 205, Winter Park, FL, USA, 32789
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
20GF Score

Get the complete analysis for ADIA

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price